MedPath

EFFEPHARM LTD

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Evaluate the Safety, Tolerability, and Efficacy of UthPeak NMNH (Reduced Nicotinamide Mononucleotide) in Healthy Adult Participants

Not Applicable
Completed
Conditions
Healthy Aging
First Posted Date
2025-03-21
Last Posted Date
2025-04-04
Lead Sponsor
EffePharm LTD
Target Recruit Count
80
Registration Number
NCT06889740
Locations
🇮🇳

Medstar Speciality Hospital, Bengaluru, Karnataka, India

🇮🇳

Vinayaka Mission's Medical College and Hospital, Karaikal, Puducherry, India

Evaluate the Efficacy and Safety of Uthever NMN(Nicotinamide Mononucleotide, a Form of Vitamin B3)

Not Applicable
Completed
Conditions
Aging
Interventions
Other: Placebo
Other: NMN
First Posted Date
2020-01-14
Last Posted Date
2021-04-01
Lead Sponsor
EffePharm LTD
Target Recruit Count
66
Registration Number
NCT04228640
Locations
🇮🇳

Swasthiye Clinic and Research Center, Pune, Maharashtra, India

🇮🇳

Dr Kamalakar Gajarae, Pune, Maharashtra, India

© Copyright 2025. All Rights Reserved by MedPath